Institutional investors hold a majority ownership of DEPO through the 89.56% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Other industry. Last, during the quarter ended December 2014, these large investors purchased a net $441.4 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ALLIANZ GLOBAL INVESTORS GMBH (U... Bought 84.4 Thousand shares of Depomed Inc
FIRST PRIVATE INVESTMENT MANAGEM... Bought 82.9 Thousand shares of Depomed Inc
SBAUER FUNDS LLC Bought 26.0 Thousand shares of Depomed Inc